Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells.

MLA

Doni Jayavelu, Naresh, et al. “Type 2 Inflammation Reduces SARS-CoV-2 Replication in the Airway Epithelium in Allergic Asthma through Functional Alteration of Ciliated Epithelial Cells.” Journal of Allergy & Clinical Immunology, vol. 152, no. 1, July 2023, pp. 56–67. EBSCOhost, https://doi.org/10.1016/j.jaci.2023.03.021.

APA

Doni Jayavelu, N., Altman, M. C., Benson, B., Dufort, M. J., Vanderwall, E. R., Rich, L. M., White, M. P., Becker, P. M., Togias, A., Jackson, D. J., & Debley, J. S. (2023). Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells. Journal of Allergy & Clinical Immunology, 152(1), 56–67. https://doi.org/10.1016/j.jaci.2023.03.021

Chicago

Doni Jayavelu, Naresh, Matthew C. Altman, Basilin Benson, Matthew J. Dufort, Elizabeth R. Vanderwall, Lucille M. Rich, Maria P. White, et al. 2023. “Type 2 Inflammation Reduces SARS-CoV-2 Replication in the Airway Epithelium in Allergic Asthma through Functional Alteration of Ciliated Epithelial Cells.” Journal of Allergy & Clinical Immunology 152 (1): 56–67. doi:10.1016/j.jaci.2023.03.021.